Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine and Capecitabine in Metastatic Breast Cancer
NCT00450515Phase 2Withdrawn
- Sponsor
- Cancer and Leukemia Group B
- Start
- Mar 2007
- Primary completion
- Jan 2009
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 2 trial of vinflunine in breast cancer, sponsored by Cancer and Leukemia Group B. Planned start Mar 2007; status: withdrawn.
02
Drugs
vinflunine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00450515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450515.